Aptean is a leading global provider of mission-critical, industry-specific enterprise resource planning (“ERP”) software that allows its customers to digitize administrative functions and drive efficiency in their operations. Aptean predominantly serves small- to medium-sized businesses in the process and discrete manufacturing end-markets. With a portfolio of over 30 products, the company provides ERP solutions that are tailor-made for industries including food and beverage, specialized tooling and industrial machinery, pharmaceuticals and medical devices, and specialty chemicals. Products also include supply chain and compliance software offerings. Aptean serves over 4,100 customers in more than 20 industries and 54 countries. The company has established a strong M&A strategy, with 26 acquisitions completed since 2012, and has developed a leadership position in food and beverage manufacturing, a segment that Charlesbank knows well. We expect to leverage our relationships in this vertical and our experience with software buy-and-build strategies to be a value-added partner to Aptean.
In August 2020, we made a strategic growth investment in Aptean through our Flagship and Technology Opportunities Funds, as the investment fits the mandate of both funds. We joined existing investors TA Associates and Vista Equity Partners as institutional shareholders in the company. As part of the transaction, TA Associates will also make a further investment in Aptean, and Charlesbank, TA Associates and Vista Equity Partners will have equal representation on the Aptean Board of Directors. The funding provides additional capital to help Aptean increase its investment in innovation and accelerate its global growth.